Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus subcutaneous deferoxamine for iron overload in thalassemia patients with heart failure
IRCT201206289827N2Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of deferoxamine in iron overload (2 arms), sponsored by Kermanshah University of Medical Sciences. Started Nov 2011; status: completed.
02
Drugs
deferoxamine
03
Conditions
iron overload
Beyond the preview
Go deeper on IRCT201206289827N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201206289827N2.